PREEKLAMPTİK HASTALARIN MATERNAL VE NEONATAL SONUÇLARININ DEĞERLENDİRİLMESİ: ÜÇÜNCÜ BASMAK BİR HASTANENİN DÖRT YILLIK DENEYİMİ

Giriş: Preeklampsi, gebeliğin ikinci yarısında ortaya çıkan, hipertansiyon ve proteinüri ile karakterize, gebeliği komplike eden multisistemik progresif bir sendromdur. Halen dünya genelinde maternal ve perinatal morbidite ve mortalitenin en önde gelen sebeplerindendir. Gereç ve Yöntem: Preeklampsi birçok maternal ve fetal komplikasyonla ilişkilidir. Biz de 2013-2017 yılları arasında kliniğimizde doğumunu gerçekleştirdiğimiz preeklamptik hastaları retrospektif olarak inceledik. Kontrol grubu olarak aynı dönemde doğumunu gerçekleştirdiğimiz, preeklamptik olmayan hastaları aldık. Grupların demografik verilerini, gebelik komplikasyonlarını, doğum şeklini, yenidoğan yoğun bakım ihtiyacını ve ölü doğum gibi neonatal komplikasyonlarını karşılaştırdık. Bulgular: Preeklamptik grubun yaş ortalaması ve nulliparite oranı istatiksel anlamlı olarak daha yüksekti (p=0,001). Doğum kilosu ve doğum haftası istatistiksel anlamlı olarak daha düşüktü (p=0,001). Fetal cinsiyet açısından gruplar arasında istatistiksel fark yoktu (p=0,452).Preeklampsi grubunda gestasyonel diyabet, preterm doğum, sezaryen doğum, primer sezaryen, yenidoğan yoğun bakımı ihtiyacı ve ölü doğum oranı istatistiksel anlamlı olarak daha yüksekti (p=0,001). Hiperemezis gravidarum ve abortus imminens açısından istatiksel olarak anlamlı fark yoktu (p=0,108; p=0,673). Sonuç: Preeklampsi halen maternal ve neonatal morbidite ve mortalitenin en başta gelen nedenlerinden biridir. Preterm eylem, gestasyonel diyabet, yenidoğan yoğun bakım ihtiyacı, sezaryen ile doğum açısından artmış risk ile birlikteliği vardır. Bu grup hastalar, alanında deneyimli personeli barındıran ve yeterli donanıma sahip üçüncü basamak merkezlerde takip ve tedavi edilmelidir.

THE MATERNAL AND NEONATAL OUTCOMES OF PREECLAMPTIC PATIENTS: FOUR YEARS EXPERIENCE OF A TERSIER HOSPITAL

Introduction: Preeclampsia, emerging in the second half of pregnancy, characterized by hypertension and proteinuria, complicating pregnancy, is a multisystemic and progressive syndrome. Preeclampsia is stillone of the leading causes of maternal and neonatal morbidity and mortality worldwide. Material and Method: Preeclampsia is related to many maternal and fetal complications. We examined the preeclamptic patients born between 2013-2017 retrospectively As the control group, we examined non-preeclamptic patients who were delivered at the same time. We compared the demographic data of the groups, pregnancy complications, delivery method, neonatal complications such as neonatal intensive care and need for newborn. Results: The age average and nulliparity ratio of the preeclamptic group were statistically significantly high (p=0,001). The birth weight and the delivery week were statistically significantly low (p=0,001). There was no difference in fetal gender between groups (p=0,452). Gestational diabetes, preterm delivery, cesarean delivery, primary cesarean section, need for neonatal intensive care and stil birth rate were significantly higher in preeclampsia group (p=0,001). There was no statistically significant difference in hyperemesis gravidarum and abortus imminens(p=0,108; p=0,673). Conclusion: Preeclampsia is still one of the leading causes of maternal and neonatal morbidity and mortality. It is associated with increased risk of preterm delivery, gestational diabetes, neonatal intensive care and cesarean section delivery. This group of patients should be followed up and treated in tertiary health care centers, which have experienced staff and adequately equipped.

PDF

___

World Health Organization. The world helath report: 2005: make every mother and child count. In Geneva; 2005. Available from: https://www.who.int/whr/2005/whr2005_en.pdf
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7.
Ananth C V, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013; 347: 6564.
Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ (Clinical research ed). 2016; 19 (353): 1753.
Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994 ;101(8):669-74.
Myatt L. Role of placenta in preeclampsia. Endocrine 2002; 19(1): 103–11.
Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014 ;121 (1):14-24.
Hung T-H, Hsieh T-T, Chen S-F. Risk of abnormal fetal growth in women with early- and late-onset preeclampsia. Pregnancy Hypertens. 2018;12:201-206.
Gibbins KJ, Silver RM, Pinar H, Reddy UM, Parker CB, Thorsten Vet al. Stillbirth, hypertensive disorders of pregnancy, and placental pathology. Placenta. 2016; 43: 61–8.
Davies EL, Bell JS, Bhattacharya S. Preeclampsia and preterm delivery: A population-based case-control study. Hypertens Pregnancy. 2016 ;35(4):510-519.
Lee J, Ouh Y-T, Ahn KH, Hong SC, Oh M-J, Kim H-Jet al. Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy. PloS One 2017; 12(5): 178150.
Amorim MMR, Katz L, Barros AS, Almeida TSF, Souza ASR, Faundes A. Maternal outcomes according to mode of delivery in women with severe preeclampsia: a cohort study. The Journal of Maternal-Fetal & Neonatal Medicine. 2015; 28(6): 654–60.
Geyl C, Clouqueur E, Lambert J, Subtil D, Debarge V, Deruelle P. [Links between preeclampsia and intrauterine growth restriction]. Gynecol Obstet Fertil 2014; 42(4):229-33
Hogberg U. The World Health Report 2005: “make every mother and child count” - including Africans. Scandinavian Journal of Public Health 2005; 33: 409–11.
Sibai BM, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. AJOG 1985; 152(1): 32–7.
Shiozaki A, Matsuda Y, Satoh S, Saito S. Impact of fetal sex in pregnancy-induced hypertension and preeclampsia in Japan. Journal of reproductive immunology. J Reprod Immunol 2011; 89(2):133-9
Elsmen E, Kallen K, Marsal K, Hellstrom-Westas L. Fetal gender and gestational-age-related incidence of pre-eclampsia. Acta Obstet Gynecol Scand. 2006; 85(11): 1285-91.
Liu Y, Li G, Zhang W. Effect of fetal gender on pregnancy outcomes in Northern China J Matern Fetal Neonatal Med. 2017; 30(7): 858-863.
Schneider S, Freerksen N, Rohrig S, Hoeft B, Maul H. Gestational diabetes and preeclampsia--similar risk factor profiles? Early Hum Dev 2012 ; 88(3):179-84.
Afrasiabi N, Mohagheghi P, Kalani M, Mohades G, Farahani Z. The effect of high risk pregnancy on duration of neonatal stay in neonatal intensive care unit. Iran J Pediatr 2014 Aug; 24(4): 423–428
Burgess APH, Katz J, Pessolano J, Ponterio J, Moretti M, Lakhi NA. Determination of antepartum and intrapartum risk factors associated with neonatal intensive care unit admission. J Perinat Med 2016; 44(5): 589–96.
Mendola P, Mumford SL, Mannisto TI, Holston A, Reddy UM, Laughon SK. Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth. Epidemiology 2015; 26(1): 17–26.
Harmon QE, Huang L, Umbach DM, Klungsoyr K, Engel SM, Magnus P, et al. Risk of fetal death with preeclampsia. Obstet Gynecol 2015;125(3):628-35.
Khader YS, Batieha A, Al-Njadat RA, Hijazi SS. Preeclampsia in Jordan: İncidence, risk factors, and its associated maternal and neonatal outcomes. J Matern Fetal Neonatal Med 2018; 31(6):770-776